Nouvelle option thérapeutique et dernières recommandations pour le traitement des femmes ménopausées à haut risque de fracture ostéoporotique

Rhumatology & Orthopedy

Nouvelle option thérapeutique et dernières recommandations pour le traitement des femmes ménopausées à haut risque de fracture ostéoporotique

Prof. Dr. Evelien Gielen et Prof. Olivier Bruyère

Au cours de cet e-learning, le Pr Bruyère et le Pr Gielen abordent la prise en charge de l’ostéoporose fracturaire (ostéoporose sévère) chez la femme ménopausée. Il est désormais établi que cette population de patientes ayant déjà présenté une fracture ostéoporotique est à très haut risque de présenter une nouvelle fracture.

Le Pr Bruyère expose les dernières recommandations concernant les différentes approches thérapeutiques en fonction du risque de fracture, mettant en avant le changement de paradigme pour le traitement des patientes à très haut risque de fracture, ainsi que les outils permettant d’évaluer le risque de fracture.

Le Pr Gielen présente une option thérapeutique récente pour la prise en charge de l’ostéoporose sévère chez la femme ménopausée et met l’accent sur l’importance de la séquence de traitement.

Professor at the department of Gerontology and Geriatrics and the Centre for Metabolic Bone Diseases in UZ Leuven, Belgium
President of the Belgian Bone Club (BBC)

Evelien Gielen, MD PhD, is associate professor and head of the research line ‘Age-related osteoporosis and sarcopenia’ at the division Gerontology and Geriatrics, Department of Public Health and Primary Care at KU Leuven. She is also deputy Head of Clinic at the Geriatric department and supervisor at the Centre for Metabolic Bone Diseases in UZ Leuven.

Evelien Gielen is involved in several (inter)national scientific projects and working groups in the field of age-related osteoporosis and sarcopenia. Her main research activities focus on strategies to promote healthy ageing and to reduce fracture risk in the very old. For both her research projects on the effects of personalized non-pharmacological interventions for persons with sarcopenia and on the role of the gut microbiota in the development and treatment of sarcopenia, she received funding from the Research Foundation Flanders.

Evelien Gielen is the president of the Belgian Bone Club and treasurer of the Belgian Aging Muscle Society. She is one of the co-authors of the 2020 guidelines of the Belgian Bone Club on the management of osteoporosis in postmenopausal women.

Voir plus Voir moins

Head of a Research Unit in Public Heath Epidemiology and Health Economics at ULiège
General Secretary of the Belgian Bone Club (BBC)

Olivier Bruyère, Ph.D., is currently Professor of Clinical Epidemiology in the Department of Public Health Sciences and of Geriatric Rehabilitation in the Department of Rehabilitation and Sport Sciences of the University of Liège in Belgium. He is head of the Research Unit in Public Health, Epidemiology and Health Economics in this University. Professor Bruyère is the Chief Executive Officer of the European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO), President of the Belgian Ageing Muscle Society (BAMS), General Secretary of the Belgian Bone Club (BBC) and member of the Scientific Advisory Board of the International Osteoporosis Foundation (IOF).

He was the Vice-President of the Human Nutrition working group at the French Agency for Food, Environmental and Occupational Health & Safety (ANSES). His main fields of interest are prevention, rehabilitation, nutrition and pharmaco-epidemiology related to geriatric or rheumatic conditions.

Besides being Editor-in-chief of the journal “The Archives of Public Health”, he is Associate Editor of “Aging Clinical and Experimental Research” as well as on the editorial board of various journals. He is author of more than 400 international scientific publications and book chapters.

Voir plus Voir moins